CVS' decision to split mirrors rising concerns about healthcare companies working as provider, insurer and pharmacy.
After a string of drugmaker losses in suits opposing the Medicare drug pricing law, AbbVie won a challenge to the inclusion of Botox in price talks. Industry experts are watching to see if more pharma players can secure exemptions.
Health intelligence platform Oura, advised by Latham & Watkins LLP, on Tuesday unveiled plans to acquire artificial intelligence-native primary care company Counsel Health, led by DLA Piper, in a $625 million deal.